The objective of this study is therefore to determine whether the expression levels of five principal clock genes, BMAL1, CLOCK, CRY1, PER1, and PER2 in the PBMCs and circulating melatonin levels are altered in PD patients compared to healthy controls (HC). This evidence concerns the gene PER2 and Parkinson disease.